Handelsavisen
prelaunch
Companies Healthcare 300753.SZ
30
300753.SZ Shenzhen Stock Exchange Medical Equipment, Supplies & Distribution

Jiangsu Apon Medical Technology Co Ltd

¥24,62
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
3,1B CNY
P/E
EV / Rev
Div yield
0,00 %
Op margin
-7,9 %
ROE
-3,6 %
Net margin
-7,0 %
Debt / equity
0,18
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Jiangsu Apon Medical Technology Co Ltd is a medical equipment and supplies company that generates revenue through the production and distribution of healthcare products.

Business. Jiangsu Apon Medical Technology Co Ltd (300753.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-3,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300753.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300753.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Jiangsu Apon Medical Technology Co Ltd (300753.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Jiangsu Apon Medical Technology Co Ltd has a market capitalization of 2.9999 billion CNY and a price-to-book ratio of 4.49, indicating a premium valuation relative to its book value. The company's liquidity position is characterized as medium, with a current ratio of 2.59, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -23.997 million CNY, and its operating cash flow is only 2.333 million CNY, indicating limited cash generation from operations.

    Profitability metrics show a challenging financial position for the company. The return on equity is -3.6%, and the return on assets is -2.79%, both significantly below the industry median for medical equipment and supplies firms. The company reported a net loss of 24.021 million CNY and an operating loss of 27.005 million CNY, reflecting a decline in profitability. Gross profit of 231.619 million CNY is a positive sign, but it is insufficient to offset the operating and net losses.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases the company's exposure to market-specific risks, particularly in the healthcare equipment and supplies industry. The absence of segment-specific revenue data limits the ability to assess the performance of individual product lines or geographic regions.

    Looking ahead, the company's growth trajectory is uncertain. The provided data does not include specific revenue growth projections for the current or next fiscal year. However, the company's negative net income and operating income suggest a need for strategic improvements to drive profitability and revenue growth. The capital expenditure of -8.435 million CNY indicates some investment in infrastructure, but the scale is relatively small compared to the company's total assets.

    The company's risk profile includes a medium liquidity risk and a low dilution risk. The key financial flag is the negative net cash position after subtracting total debt, which could impact the company's ability to meet short-term obligations. The debt-to-equity ratio of 0.18 suggests a conservative capital structure, with limited leverage. However, the company's negative free cash flow and operating cash flow indicate potential challenges in maintaining financial flexibility.

    Recent events and filings do not provide specific details on the company's strategic initiatives or operational changes. The absence of recent transcripts or filings limits the ability to assess the company's management's outlook and plans for addressing its financial challenges. The company's financial performance and risk profile suggest a need for close monitoring of its operational and financial strategies to ensure long-term sustainability.

    Key takeaways
    • Jiangsu Apon Medical Technology Co Ltd is a medical equipment and supplies company with a market capitalization of 2.9999 billion CNY.
    • The company has a price-to-book ratio of 4.49 and a current ratio of 2.59, indicating a premium valuation and sufficient short-term liquidity.
    • The company reported a net loss of 24.021 million CNY and an operating loss of 27.005 million CNY, reflecting a decline in profitability.
    • The company's revenue is concentrated in a single business segment, increasing its exposure to market-specific risks.
    • The company's risk profile includes a medium liquidity risk and a low dilution risk, with a key financial flag being the negative net cash position after subtracting total debt.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥24,62
    Market cap
    ¥3.00B
    Enterprise value
    ¥3.12B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    1336.8x
    P / B
    4.5x
    P / Tangible book
    4.5x
    Tangible book
    ¥667.4M
    Net cash
    -¥118.6M
    Current ratio
    2.6
    Debt / equity
    0.2
    ROA
    -2.8%
    ROE
    -3.6%
    Cash conversion
    -10.0%
    CapEx / revenue
    -2.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-7,9 %Below median
    Net Margin-7,0 %Below median
    ROE-3,6 %Below median
    Capex / Rev-2,5 %Above P75
    D/E0,18Above median
    Cash Conv-0,10Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Jiangsu Apon Medical Technology Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300753.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage